MTA TTK Lendület Cancer Biomarker Research Group Hungary

Research

Date range: 1 February 2022 - 31 January 2023

Region: Global
Subject/journal group: All

The table to the right includes counts of all research outputs for MTA TTK Lendület Cancer Biomarker Research Group published between 1 February 2022 - 31 January 2023 which are tracked by the Nature Index.

Hover over the donut graph to view the Share for each subject. Below, the same research outputs are grouped by subject. Click on the subject to drill-down into a list of articles organized by journal, and then by title.

Note: Articles may be assigned to more than one subject area.

Article Count and Share for MTA TTK Lendület Cancer Biomarker Research Group
Count Share
1 0.02

Outputs by subject (Share)

Outputs by subject
Subject Count Share
1 0.02

Share output for the past 5 years

Share per year
2018 2019 2020 2021 2022
0.28 0.12 0.00 0.11 0.00

Compare MTA TTK Lendület Cancer Biomarker Research Group with other institutions

Nature Strategy Reports

Nature Strategy Reports gives you simple insights to support decisions that impact your organisation

The reports created for you by our subject matter experts combine compelling insights with Nature’s trust and authority. Get an in-depth analysis of your and your peers’ research performance, including a breakdown of relative strengths and weaknesses. All of which is crafted using data and tools from across Nature Research Intelligence, covering all major disciplines and all regions of the world.

Get started

Collaboration

Date range: 1 February 2022 - 31 January 2023

International vs. domestic collaboration by Share

  • 6.90% Domestic (2 institutions)
  • 93.10% International (4 institutions)

Hover over the graph to view the percentage of collaboration.

Top 10 domestic collaborators with MTA TTK Lendület Cancer Biomarker Research Group by Share*

  1. MTA TTK Lendület Cancer Biomarker Research Group and Semmelweis University (SE) (0.05)
    MTA TTK Lendület Cancer Biomarker Research Group0.02
    Semmelweis University (SE)0.03
  2. MTA TTK Lendület Cancer Biomarker Research Group and Hungarian Academy of Sciences (HAS) (0.03)
    MTA TTK Lendület Cancer Biomarker Research Group0.02
    Hungarian Academy of Sciences (HAS)0.01

Top 10 international collaborators with MTA TTK Lendület Cancer Biomarker Research Group by Share*

  1. MTA TTK Lendület Cancer Biomarker Research Group and University of Michigan (U-M) (0.87)
    MTA TTK Lendület Cancer Biomarker Research Group0.02
    University of Michigan (U-M)0.85
  2. MTA TTK Lendület Cancer Biomarker Research Group and National Institutes of Health (NIH) (0.10)
    MTA TTK Lendület Cancer Biomarker Research Group0.02
    National Institutes of Health (NIH)0.08
  3. MTA TTK Lendület Cancer Biomarker Research Group and Ain Shams University (0.04)
    MTA TTK Lendület Cancer Biomarker Research Group0.02
    Ain Shams University0.02
  4. MTA TTK Lendület Cancer Biomarker Research Group and U.S. Department of Veterans Affairs (0.03)
    MTA TTK Lendület Cancer Biomarker Research Group0.02
    U.S. Department of Veterans Affairs0.01

*Share is the fractional count allocated to an institution for an article that takes into account the percentage of authors from that institution and the number of affiliated institutions that contributed to the article. The horizontal stacked bar charts above indicate the Share contributed by each institution in the bilateral collaboration. If the Share is not shown, hover over the bar to display it.

Relationships

Partner Institutions

MTA TTK Lendület Cancer Biomarker Research Group is a research collaboration whose article contributions are accrued to its participating partner institutions below.


Numerical information only is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.